Apr 9, 2025, 08:08 AM by

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today announced a significant expansion of its APAC distributor network. This development marks a key milestone in the Company’s global commercial strategy to meet growing demand for its next-generation single-cell analysis platforms.

Apr 9, 2025, 01:00 AM by User Not Found

Bio-IT World | At the opening plenary panel at last week’s Bio-IT World Conference & Expo, speakers from pharma, healthcare, and biotech took on the future of AI for pharma and healthcare. Abbie Celniker, Partner, Third Rock Ventures, moderated the conversation which included viewpoints from Per Greisen, President, BioMap; Sofia Guerra, Vice President, Bessemer Venture Partners; Subha Madhavan, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Pfizer; and Sonya Makhni, MD, Medical Director, Mayo Clinic Platform.

Apr 8, 2025, 08:17 AM by

Indivumed is proud to announce major milestones achieved, cementing its position as a leading oncology R&D company.

Apr 8, 2025, 01:00 AM by User Not Found

Bio-IT World| Oral drugs are considered an ideal delivery method for medications because of their noninvasive nature, but they face the challenge of passing through the acidic environment of the upper gastrointestinal (GI) tract. Specifically, the stomach acts as a barrier to anything biological, including oral drugs with biologic content. To overcome this obstacle, a team of researchers at Virginia Tech engineered microbes called bacteriophages, or phages, to infect and reprogram gut bacterial cells to produce and release a sustained flow of a protein-based drug.

Apr 4, 2025, 11:52 AM by User Not Found

Bio-IT World | Yesterday in Boston the Bio-IT World community at the Bio-IT World Conference & Expo honored four new products in the annual Bio-IT World Best of Show competition. New products from Boulder BioComputing, Dantech Corp, The Hyve, and Velsera took top honors.

Apr 3, 2025, 12:56 PM by

Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb

Apr 3, 2025, 12:56 PM by

Company prioritizes industry insights on key themes to transform clinical research through innovation in annual Industry Outlook report

Apr 3, 2025, 12:53 PM by

Apr 3, 2025, 12:49 PM by

Israeli startup ProFuse has launched a new drug discovery platform to develop therapies that prevent muscle loss associated with GLP-1 weight-loss drugs, aging, and cancer. The platform uses lab-grown, highly mature human muscle tissues and automated screening to identify promising drug candidates, reducing reliance on animal testing and accelerating development timelines. The company also announced the appointment of veteran life sciences investor Anat Naschitz to its board.

Apr 3, 2025, 12:49 PM by

Apr 3, 2025, 12:47 PM by

Apr 3, 2025, 12:46 PM by

The Chinese pharmaceutical business United Laboratories International offered the Danish manufacturer up to $2 billion for the rights to an experimental medicine. In addition to tiered royalties, Novo Nordisk will make milestone payments of up to $1.8 billion and an upfront payment of $200 million.

Apr 3, 2025, 01:00 AM by User Not Found

Bio-IT World| Weight loss medications are in “skyrocketing” utilization. Yet there have been no comprehensive investigations or studies on the effectiveness and risks of glucagon-like peptide-1 receptor agents (GLP-1RA). Researchers at the WashU Medicine collaborated with the Veterans Affairs (VA) St. Louis Health Care System to examine and evaluate more than two million people with diabetes taking popular weight loss drugs such as Ozempic.

Apr 2, 2025, 01:00 AM by User Not Found

Bio-IT World| In the largest phenome wide association study across diverse population groups, an international team of researchers have identified 254 statistically significant associations between genetically explained height and various diseases. Genetically predicted height was linked with decreased risk of 90 diseases and increased risk of 164 others, most notably atrial fibrillation, and a series of conditions involving mental health and the endocrine system that have not been previously described.

Apr 1, 2025, 11:38 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has today announced Usama Dar as its new Chief Product and Technology Officer.

Apr 1, 2025, 11:38 AM by

AMP announced a favorable ruling in its lawsuit against the U.S. FDA over the regulation of laboratory-developed test procedures.

Apr 1, 2025, 11:38 AM by

First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody producing cells

Apr 1, 2025, 11:38 AM by

Apr 1, 2025, 11:38 AM by

DoseMe, a leading provider of model-informed precision dosing (MIPD), today announced Inspira has expanded the implementation of the dosing platform to serve the newly acquired Mannington site. Inspira has used DoseMeRx since 2020 and integrates with EHR software for faster, efficient access to patient profiles for overall better quality of care.

Mar 28, 2025, 01:00 AM by User Not Found

Bio-IT World| Finalists have been named for the 2025 Bio-IT World Best of Show Awards program. More than 20 new products will be on display next week at the Bio-IT World Conference & Expo. New products will be on display from Artificial, Boulder BioComputing, Copyright Clearance Center, Chemspace, Dantech Corporation, Discngine, expert.ai, Genomenon, Globus, GRAU DATA, iuvo, Komprise, Orchestra Bio, Quantum Corporation, QuartzBio, Sinequa, Tech Mahindra, TetraScience, The Hyve, and Velsera.